Products

Blue Genes AI-Powered Pharmacogenetics
Blue Genes
Clinical Decision Support & Reference
Blue Genes is a leading pharmacogenetics (PGx) solution that leverages AI to provide real-time suggestions of clinically appropriate alternative therapies based on pharmacogenomic data, supporting safer prescribing and reducing administrative load for providers.

See all 1 product →

About Blue Genes

Blue Genes is a healthcare AI company focused on transforming medication decisions through real-time pharmacogenetics. Their AI-powered platform aims to proactively prevent harmful prescriptions and adverse drug reactions by providing immediate, data-driven recommendations to healthcare providers. The company’s mission is to eliminate genetically driven adverse drug reactions, protect patients, reduce preventable costs for health plans, and bring precision to every prescription decision.

The platform integrates complex genetic insights into clear, actionable guidance at the point of care, helping providers understand how a patient’s unique DNA impacts their response to medications. Blue Genes offers an app-based tool that considers both drug-drug and gene-drug interactions to suggest optimal medications. They also leverage Google’s Gemini AI and Google Cloud to streamline communication with patients and providers through intelligent voice and chat agents, offering HIPAA-aware support and real-time suggestions for alternative therapies when prescriptions are denied.

Blue Genes’ solutions are designed for system compatibility, integrating with Pharmacy Benefit Managers (PBMs), Electronic Medical Records (EMRs), and pharmacy systems. This integration allows for real-time claim denials if a prescribed medication is not efficacious for a patient based on their genetics, without requiring behavioral changes from patients or adding significant administrative burden to providers. They also offer a personalized, at-home genetic testing kit.

Focus Areas

pharmacogenetics precision medicine AI in healthcare adverse drug reaction prevention medication management genetic testing real-time clinical support

Business Intelligence

TechnologyAI-powered platform, Google's Gemini AI, Google Cloud, patent-pending technology, API for PBM and EMR integration, cloud-native

What Physicians Need to Know

Pharmacogenomics (PGx) Integration
Blue Genes specializes in integrating pharmacogenomic insights directly into healthcare workflows, enabling real-time, personalized prescribing decisions. Their platform helps providers understand how a patient's unique DNA impacts their response to medications, aiming to reduce adverse drug reactions by 50% and avoid unnecessary or ineffective prescriptions.
AI-Powered Clinical Support
The company leverages AI, including Google's Gemini AI, to provide rapid and informed answers to both providers and patients. This includes real-time recommendations for alternative medications based on FDA data, case studies, and peer-reviewed literature.
Real-Time Intervention at Point of Care
Blue Genes' patent-pending technology delivers secure, scalable access to PGx insights at the point of care, ensuring lightning-fast response times (sub-second latency) for smooth integration with existing systems and minimal disruption to clinical workflows.
Automated Communication Tools
They offer AI-powered intelligent voice and chat agents built on Google Cloud to streamline and personalize communication with patients and providers. These tools handle tasks like reminding patients about genetic test kits, explaining claim denials, and suggesting alternative therapies to doctors.
Comprehensive Genetic Analysis
Blue Genes provides an app-based tool that considers both drug-drug and gene-drug interactions to suggest the best medications for a patient. They also offer at-home testing kits for genetic incompatibility and drug-to-drug interactions.
GLP-1 Related Gene Analysis
Blue Genes has expanded its clinical testing panel to include genes that influence GLP-1 biology, aiming to improve personalized treatment strategies for metabolic conditions like type 2 diabetes and obesity.
Physician Tip

For physicians, Blue Genes offers a powerful tool to move beyond trial-and-error prescribing by providing real-time, personalized medication guidance based on a patient's genetic profile. The platform integrates seamlessly into existing EMRs and PBMs, delivering actionable insights at the point of care without requiring significant changes to clinical workflows. AI-powered clinical support and communication tools reduce administrative burden, offer immediate suggestions for alternative therapies, and help ensure compliance, allowing physicians to focus on delivering exceptional patient care. The goal is to empower providers to prescribe with confidence, reduce adverse drug reactions, and improve patient outcomes by aligning medications with individual genetic profiles.

Blue Genes' platform is designed for seamless integration with leading Pharmacy Benefit Managers (PBMs) and Electronic Medical Records (EMRs). They utilize an open-source API that can be integrated into adjudication engines for real-time claim processing and medication guidance. The company has active partnerships with various PBMs and healthcare technology companies like Levrx and RxSense to embed precision medicine into existing benefit infrastructures.

Products by Blue Genes

1 product in the directory

Blue Genes AI-Powered Pharmacogenetics
Blue Genes
Clinical Decision Support & Reference
Blue Genes is a leading pharmacogenetics (PGx) solution that leverages AI to provide real-time suggestions of clinically appropriate alternative therapies based on pharmacogenomic data, supporting safer prescribing and reducing administrative load for providers.

Reviews & Opinions

No web reviews on file yet for Blue Genes. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Blue Genes.

Loading videos...

Videos load interactively. If none appear, search YouTube for Blue Genes →

View all on YouTube

Press & Coverage

Blue Genes
TRU-1 By Blue Genes Launches to Advance Precision Health Through Smarter Genetic Insights
Blue Genes launched TRU-1, a new platform for precision wellness that provides genetic insights into individual responses to wellness strategies, supplements, and GLP-1 related programs. This expands Blue Genes' personalized health technologies, offering accessible genetic testing and digital health tools.
2026-05
Liviniti
Liviniti and BlueGenes Collaborate for Safer, More Effective Medication Management
Liviniti and BlueGenes announced a collaboration to provide Liviniti members with access to BlueGenes' pharmacogenomic (PGx) testing. This partnership aims to integrate genetic data with PBMs and EMRs to optimize clinical prescribing decisions in real-time, improving patient safety and reducing healthcare costs.
2026-08
Blue Genes
Blue Genes Partners with RxSense to Deliver Actionable PGx at the Point of Adjudication
Blue Genes and RxSense have partnered to integrate precision medicine insights into pharmacy benefit workflows, making pharmacogenomics (PGx) actionable at the point of adjudication. This collaboration will help PBMs and plan sponsors optimize medication decisions in real-time, reducing trial-and-error prescribing.
2026-02
Blue Genes
Blue Genes Successfully Completes SOC 2 Audit
Blue Genes announced the successful completion of its SOC 2 Type II examination as of January 16, 2025. This audit signifies the company's commitment to data security and compliance in its pharmacogenetic testing and genetic insights services.
2026-01
Oxford Academic (Synthetic Biology)
Optogenetic BlueGENEs engineered into a human safe harbor locus
This peer-reviewed article details the development of BlueGENEs, optimized optogenetic gene switches that support rapid, stable cell line generation and precision engineering into the human AAVS1 safe harbor locus. This technology has implications for crafting synthetic in vitro tissues and controlling cellular functions with light.
2026-01
Blue Genes
Blue Genes Lab Expands Genetic Panel to Include Three New GLP-1u2013Related Genes
Blue Genes Lab has expanded its clinical testing panel to include three new genes that influence GLP-1 biology. This expansion aims to improve personalized treatment strategies for metabolic conditions like type 2 diabetes and obesity.
2025-09
Blue Genes
Blue Genes and Levrx Partner to Integrate Real-Time Genetic Insights into the Pharmacy Benefit Experience
Blue Genes and Levrx Technology have formed a strategic partnership to integrate real-time genetic insights into pharmacy benefit systems. This collaboration aims to accelerate the adoption of personalized prescribing and reduce adverse drug reactions.
2025-06
Blue Genes
Blue Genes Partners with Level Care to Revolutionize Medication Management for Union Members
Blue Genes announced a strategic partnership with Level Care, the healthcare division of the carpenters union, to provide members with access to pharmacogenomic (PGX) testing. This aims to ensure safer and more effective medication management by integrating genetic data into prescribing decisions.
2025-04

Frequently Asked Questions

Blue Genes offers an AI-powered pharmacogenomics (PGx) platform that provides real-time drug interaction and prescription drug delivery insights. Their AI tools, powered by Google's Gemini AI, include intelligent voice and chat agents for patient and provider communication, offering 24/7 support, explaining claim denials, and suggesting alternative therapies based on pharmacogenomic data.
Blue Genes states that all genetic and health-related data is stored and transmitted in compliance with HIPAA security rules. They also indicate that they do not use genetic data for marketing or share it with third parties without explicit consent, and they employ industry-standard safeguards like encryption and secure access controls.
While specific pricing details for Blue Genes' core pharmacogenomics platform are not publicly available, they mention that for their GLP-1 genetic testing, a one-time test can offset thousands in wasted therapy spend. Another company named BlueGenAI, which focuses on government AI solutions, is finalizing flexible pricing options for integrators, government agencies, and enterprise-scale modernization efforts.
Blue Genes provides customer support via email and phone, and they have a dedicated support center to assist with questions, concerns, or issues. They also offer consultations with experienced PharmD team members to help users understand their pharmacogenomic reports.
Blue Genes has established several strategic partnerships, including with RxSense to integrate PGx insights into pharmacy benefit workflows, with Levrx Technology to integrate genetic insights into the pharmacy benefit experience, and with Level Care to provide pharmacogenomic testing to union members. They also leverage Google's Gemini AI and Google Cloud for their AI communication tools.
Blue Genes was founded in 2022 and is currently an unfunded company. It operates as a privately held company with no external backing and has 574 active competitors.
Blue Genes' patent-pending technology is designed for seamless integration with existing systems, including EMRs and PBMs. Their API delivers real-time pharmacogenomic insights at the point of care and is built for system compatibility to minimize disruption to clinical workflows.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]

The Utah Medical Licensing Board is a state governmental agency responsible for regulating the licensing and practice of medical professionals within Utah. It operates under the Utah Division of Professional Licensing (DOPL), which is part of the Department of Commerce. The Board’s primary function is to ensure the health and safety of Utah citizens by […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.